{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:17:24Z","timestamp":1792073844342,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12328-022-01734-1","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T08:10:40Z","timestamp":1669709440000},"page":"216-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrence of hepatocellular carcinoma after radiofrequency ablation in a poor-risk patient with chronic renal failure and other complications successfully treated with stereotactic body radiotherapy"],"prefix":"10.1007","volume":"16","author":[{"given":"Toyokazu","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4366-1699","authenticated-orcid":false,"given":"Satoshi","family":"Takakusagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5924-1170","authenticated-orcid":false,"given":"Hitoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youzo","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Kizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Marubashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kosone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5224-8505","authenticated-orcid":false,"given":"Hiroki","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-4331","authenticated-orcid":false,"given":"Toshio","family":"Uraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"1734_CR1","doi-asserted-by":"publisher","first-page":"23416","DOI":"10.18632\/aging.203620","volume":"13","author":"RIR Macias","year":"2021","unstructured":"Macias RIR, Monte M, Serrano M, et al. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics. Aging. 2021;13:23416\u201334.","journal-title":"Aging"},{"key":"1734_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/JHC.S101448","volume":"3","author":"A Brunot","year":"2016","unstructured":"Brunot A, Sourd SL, Pracht M, et al. Hepatocellular carcinoma in elderly patients: challenges and solutions. J Hepatocell Carcinoma. 2016;3:9\u201318 (eCollection 2016).","journal-title":"J Hepatocell Carcinoma"},{"key":"1734_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jgh3.12459","volume":"5","author":"S Takakusagi","year":"2020","unstructured":"Takakusagi S, Takagi H, Kosone T, et al. Prognosis of late elderly patients with chronic hepatitis C after achieving a sustained viral response by direct-acting antivirals. JGH Open. 2020;5:122\u20137 (eCollection 2021 Jan).","journal-title":"JGH Open"},{"key":"1734_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.7793\/jcoron.18.011","volume":"18","author":"S Ikuta","year":"2012","unstructured":"Ikuta S, Kobayashi N, Yasuda M, et al. Treatment of elderly patients with cardiovascular disease who have multiple complications and comorbidities. J Jpn Coron Assoc. 2012;18:98\u2013102.","journal-title":"J Jpn Coron Assoc"},{"key":"1734_CR5","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/hepr.13411","volume":"49","author":"N Kokudo","year":"2019","unstructured":"Kokudo N, Takemura N, Hasegawa K, et al. Clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2017(4th JSH-HCC guide lines). Hepatol Res. 2019;49:1109\u201313.","journal-title":"Hepatol Res"},{"key":"1734_CR6","first-page":"714","volume":"13","author":"R Phillips","year":"1960","unstructured":"Phillips R, Murikami K. Preliminary neoplasms of the liver. Results Radiat Ther Cancer. 1960;13:714\u201320.","journal-title":"Results Radiat Ther Cancer"},{"key":"1734_CR7","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/0360-3016(89)90530-0","volume":"17","author":"GB Stillwagon","year":"1989","unstructured":"Stillwagon GB, Order SE, Guse C, et al. 194 Hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a radiation therapy oncology group study. Int J Radiat Oncol Biol Phys. 1989;17:1223\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1734_CR8","doi-asserted-by":"publisher","first-page":"23416","DOI":"10.18632\/aging.203620","volume":"13","author":"RIR Macias","year":"2021","unstructured":"Macias RIR, Monte MJ, Serrano MA, et al. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics. Aging (Albany NY). 2021;13:23416\u201334.","journal-title":"Aging (Albany NY)"},{"key":"1734_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.35772\/ghm.2020.01086","volume":"2","author":"T Kokudo","year":"2020","unstructured":"Kokudo T, Kokudo N. What liver surgeons have achieved in the recent decade for patients with hepatocellular carcinoma? Glob Health Med. 2020;2:265\u20138.","journal-title":"Glob Health Med"},{"key":"1734_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/01.sla.0000167925.90380.fe","volume":"242","author":"GT Huang","year":"2005","unstructured":"Huang GT, Lee PH, Tsang YM, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg. 2005;242:36\u201342.","journal-title":"Ann Surg"},{"key":"1734_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","volume":"243","author":"MS Chen","year":"2006","unstructured":"Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243:321\u20138.","journal-title":"Ann Surg"},{"key":"1734_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jhep.2012.05.007","volume":"57","author":"K Feng","year":"2012","unstructured":"Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012;57:794\u2013802.","journal-title":"J Hepatol"},{"key":"1734_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000521665","volume":"11","author":"T Takayama","year":"2021","unstructured":"Takayama T, Hasegawa K, Izumi N, et al. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial). Liver Cancer. 2021;11:209\u201318.","journal-title":"Liver Cancer"},{"key":"1734_CR14","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","volume":"252","author":"J Huang","year":"2010","unstructured":"Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252:903\u201312.","journal-title":"Ann Surg"},{"key":"1734_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00000658-199804000-00018","volume":"227","author":"EJ Patterson","year":"1998","unstructured":"Patterson EJ, Scudamore CH, Owen DA, et al. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg. 1998;227:559\u201365.","journal-title":"Ann Surg"},{"key":"1734_CR16","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1111\/hepr.12264","volume":"44","author":"H Iida","year":"2014","unstructured":"Iida H, Aihara T, Ikuta S, et al. Comparative study of percutaneous radiofrequency ablation and hepatic resection for small, poorly differentiated hepatocellular carcinomas. Hepatology Res. 2014;44:E156\u201362.","journal-title":"Hepatology Res"},{"key":"1734_CR17","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1200\/JCO.1993.11.7.1286","volume":"11","author":"JM Robertson","year":"1993","unstructured":"Robertson JM, Lawrence TS, Dworzanin LM, et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol. 1993;11:1286\u201393.","journal-title":"J Clin Oncol"},{"key":"1734_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.radonc.2007.07.005","volume":"84","author":"R Toya","year":"2007","unstructured":"Toya R, Murakami R, Baba Y, et al. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother Oncol. 2007;84:266\u201371.","journal-title":"Radiother Oncol"},{"key":"1734_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.radonc.2007.07.021","volume":"84","author":"M Xi","year":"2007","unstructured":"Xi M, Liu MZ, Deng XW, et al. Defining internal target volume (ITV) for hepatocellular carcinoma using four-dimensional CT. Radiother Oncol. 2007;84:272\u20138.","journal-title":"Radiother Oncol"},{"key":"1734_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.radonc.2007.12.006","volume":"87","author":"JD Zhao","year":"2008","unstructured":"Zhao JD, Xu ZY, Zhu J, et al. Application of active breathing control in 3- dimensional conformal radiation therapy for hepatocellular carcinoma: the feasibility and benefit. Radiother Oncol. 2008;87:439\u201344.","journal-title":"Radiother Oncol"},{"key":"1734_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jhep.2020.03.005","volume":"73","author":"N Kim","year":"2020","unstructured":"Kim N, Cheng J, Jung I, et al. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma. J Hepatol. 2020;73:121\u20139.","journal-title":"J Hepatol"},{"key":"1734_CR22","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1002\/hep.30591","volume":"69","author":"K Hara","year":"2019","unstructured":"Hara K, Takeda A, Tsurugai Y, et al. Radiotherapy for hepatocellular carcinoma results in comparable survival to radiofrequency ablation: a propensity score analysis. Hepatology. 2019;69:2533\u201345.","journal-title":"Hepatology"},{"key":"1734_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ijrobp.2009.02.030","volume":"76","author":"S Sugahara","year":"2010","unstructured":"Sugahara S, Oshiro Y, Nakayama H, et al. Proton beam therapy for large hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2010;76:460\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1734_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.radonc.2018.10.009","volume":"132","author":"K Shibuya","year":"2019","unstructured":"Shibuya K, Ohno T, Kato H, et al. A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3\u00a0cm or larger. Radiother Oncol. 2019;132:230\u20135.","journal-title":"Radiother Oncol"},{"key":"1734_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13014-015-0491-8","volume":"10","author":"T Abe","year":"2015","unstructured":"Abe T, Saitoh J, Kobayashi D, et al. Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma. Radiat Oncol. 2015;10:187.","journal-title":"Radiat Oncol"},{"key":"1734_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.21037\/jgo.2019.04.02","volume":"11","author":"M Chuong","year":"2020","unstructured":"Chuong M, Kaiser A, Molitoris J, et al. Proton beam therapy for liver cancers. J Gastrointest Oncol. 2020;11:157\u201365.","journal-title":"J Gastrointest Oncol"},{"key":"1734_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000520277","volume":"11","author":"K Shibuya","year":"2022","unstructured":"Shibuya K, Katoh H, Koyama Y, et al. Efficacy and Safety of 4 fractions of carbon-ion radiation therapy for hepatocellular carcinoma: a prospective study. Liver Cancer. 2022;11:61\u201374.","journal-title":"Liver Cancer"},{"key":"1734_CR28","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.3748\/wjg.v27.i26.4104","volume":"27","author":"H Yeh","year":"2021","unstructured":"Yeh H, Chiang C, Yen T, et al. Hepatocellular carcinoma in patients with renal dysfunction: pathophysiology, prognosis, and treatment challenges. World J Gastroenterol. 2021;27:4104\u201342.","journal-title":"World J Gastroenterol"},{"key":"1734_CR29","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1007\/s00268-018-4698-3","volume":"42","author":"C Shirata","year":"2018","unstructured":"Shirata C, Hasegawa K, Kokudo T, et al. Liver resection for hepatocellular carcinoma in patients with renal dysfunction. World J Surg. 2018;42:4054\u201362.","journal-title":"World J Surg"},{"key":"1734_CR30","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3748\/wjg.v11.i14.2067","volume":"11","author":"CN Yeh","year":"2005","unstructured":"Yeh CN, Lee WC, Chen MF. Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol. 2005;11:2067\u201371.","journal-title":"World J Gastroenterol"},{"key":"1734_CR31","first-page":"249","volume":"40","author":"M Yamagata","year":"1993","unstructured":"Yamagata M, Kanematsu T, Matsumata T, et al. Possibility of hepatic resection in patients on maintenance hemodialysis. Hepatogastroenterology. 1993;40:249\u201352.","journal-title":"Hepatogastroenterology"},{"key":"1734_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/jso.1160","volume":"78","author":"SB Cheng","year":"2001","unstructured":"Cheng SB, Wu CC, Shu KH, et al. Liver resection for hepatocellular carcinoma in patients with end-stage renal failure. J Surg Oncol. 2001;78:241\u20136.","journal-title":"J Surg Oncol"},{"key":"1734_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/jgh.12669","volume":"30","author":"CF Chen","year":"2015","unstructured":"Chen CF, Liu PH, Lee YH, et al. Impact of renal insufficiency on patients with hepatocellular carcinoma undergoing radiofrequency ablation. J Gastroenterol Hepatol. 2015;30:192\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"1734_CR34","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s10147-020-01621-0","volume":"25","author":"H Hirota","year":"2020","unstructured":"Hirota H, Ito K, Kageyama S, et al. Safety of radiotherapy for hemodialysis patients with cancer. Int J Clin Oncol. 2020;25:978\u201383.","journal-title":"Int J Clin Oncol"},{"key":"1734_CR35","first-page":"e22214","volume":"14","author":"Y Takakusagi","year":"2022","unstructured":"Takakusagi Y, Suga M, Kusano Y, et al. Evaluation of safety for scanning carbon-ion radiotherapy in hemodialysis patients with prostate cancer. Cureus. 2022;14:e22214.","journal-title":"Cureus"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-022-01734-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-022-01734-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-022-01734-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T10:37:52Z","timestamp":1680172672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-022-01734-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1734"],"URL":"https:\/\/doi.org\/10.1007\/s12328-022-01734-1","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this manuscript involving human were in accordance with ethical standards of the institutional and\/or national research  committee and with the 1964 Helsinki declaration and its later amendments of comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}},{"value":"This is a case report, and we obtained the formal informed consent by the patient reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}